Outcomes of cardiac involvement in patients with late-stage duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital

Cardiology

Volumn 121, Issue 3, 2012, Pages 186-193

  Kwon, Sung Woo ^a   Kang, Seong Woong ^b   Kim, Jong Youn ^b   Choi, Eui Young ^b   Yoon, Young Won ^b   Park, Yoo Mi ^b   Ma, Dae Won ^b   Chung, Hyemoon ^b   Kwon, Hyuck Moon ^b   Rim, Se Joong ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiac involvement; Dilated cardiomyopathy; Duchenne muscular dystrophy; Echocardiography; Left ventricular ejection fraction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY REHABILITATION; REHABILITATION CENTER; RESPIRATORY FAILURE; TERTIARY HEALTH CARE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HOSPITALIZATION; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; POSITIVE-PRESSURE RESPIRATION; REHABILITATION CENTERS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84859641895     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000336810     Document Type: Article

References (24)

1. Finsterer J, Stollberger C: The heart in human dystrophinopathies. Cardiology 2003; 99: 1-19. (Pubitemid 36206630)
2. Hoffman EP, Brown RH Jr, Kunkel LM: Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-928.
3. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robinson J, Schierbecker J: Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy. Neurology 1989; 39: 475-481. (Pubitemid 19105758)
4. Cox GF, Kunkel LM: Dystrophies and heart disease. Curr Opin Cardiol 1997; 12: 329-343. (Pubitemid 27252541)
5. Perloff JK, De Leon AC Jr, O'Doherty D: The cardiomyopathy of progressive muscular dystrophy. Circulation 1966; 33: 625-648.
6. Ishikawa Y, Miura T, Ishikawa Y, et al: Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscul Disord 2011; 21: 47-51.
7. Kang SW: Pulmonary rehabilitation in patients with neuromuscular disease. Yonsei Med J 2006; 47: 307-314.
8. Swinyard DA, Deaver GG, Grenspan L: Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular disease. Arch Phys Med Rehabil 1957; 38: 574-579.
9. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003; 42: 954-970.
10. Sasaki K, Sakata K, Kachi E, Hirata S, Ishihara T, Ishikawa K. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: A two-dimensional echocardiographic study. Am Heart J 1998; 135: 937-944. (Pubitemid 28316988)
11. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K: Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12: 926-929.
12. Finder JD: A 2009 perspective on the 2004 American Thoracic Society statement, 'Respiratory Care of the Patient with Duchenne Muscular Dystrophy'. Pediatrics 2009; 123:S239-S241.
13. Simonds AK: Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130: 1879-1886. (Pubitemid 46033449)
14. Bushby K, Finkel R, Birnkrant DJ, et al: Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care. Lancet Neurol 2010; 9: 177-189.
15. Finder JD, Birnkrant D, Carl J, et al: Respiratory care of the patient with Duchenne muscular dystrophy: An official ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456-465. (Pubitemid 39214623)
16. Ishikawa Y, Bach JR, Minami R: Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 1999; 137: 895-902.
17. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA: Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005; 112: 2799-2804. (Pubitemid 41641674)
18. Kajimoto H, Ishigaki K, Okumura K, Tomimatsu H, Nakazawa M, Saito K, Osawa M, Nakanishi T: Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006; 70: 991-994. (Pubitemid 44161734)
19. Ogata H, Ishikawa Y, Ishikawa Y, Minami R: Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 2009; 53: 72-78.
20. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Bécane HM: Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005; 45: 855-857. (Pubitemid 40342808)
21. Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane HM: Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007; 154: 596-602. (Pubitemid 47268252)
22. English KM, Gibbs JL: Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 2006; 48: 231-235. (Pubitemid 44404273)
23. Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI: Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study. Lancet 2003; 361: 1843-1848. (Pubitemid 36645177)
24. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K: Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr Cardiol 2002; 23: 160-166. (Pubitemid 36927893)